Overview

Use of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematology

Status:
Completed
Trial end date:
2016-01-27
Target enrollment:
Participant gender:
Summary
The purpose of this observational study is to describe the actual conditions of prescription of micafungin in antifungal prophylaxis in French haematological and onco-haematological units. The efficacy and the safety outcomes will be described.
Details
Lead Sponsor:
Astellas Pharma S.A.S.
Treatments:
Antifungal Agents
Echinocandins
Micafungin
Miconazole